Thus we hypothesized that, in RSA patients, it is possible that a poorly vascularized (hypoxic) placenta stimulates excessive sFlt-1 and VEGF production throughout early gestation, stimulating additional sFlt-1 release, leading to endothelial dysfunction and miscarriage. The gene discussed is VEGFA; the disease is Miscarriage.